Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer
Laila Akl, Amer Ali Abd El‐Hafeez, Tamer M. Ibrahim, Rofaida Salem, Hala Mohamed M. Marzouk, Ramadan A. El-Domany, Pradipta Ghosh, Wagdy M. Eldehna, Sahar M. Abou‐Seri
Topics & Concepts
Cyclin-dependent kinase 1ChemistryKinaseCell cycleCancer researchCell cultureIC50Pancreatic cancerIn vitroPharmacologyCellBiochemistryCancerInternal medicineBiologyMedicineGeneticsCancer-related Molecular PathwaysNeuroblastoma Research and TreatmentsCancer therapeutics and mechanisms